Canceling All Activity Regarding Attempts To Sell Face Masks
WEST PALM BEACH, Florida, March 31, 2020 (GLOBE NEWSWIRE) -- Praxsyn (OTC: PXYN, the “Company”) on February 27, 2020 and March 4, 2020 concerning our attempt to sell millions of masks meeting the NIOSH N95 mask standard and similar standards, capable of protecting wearers from breathing in viruses, including Novel Coronavirus COVID-19.
While we had stated in our second press release that we were evaluating multiple orders and vetting various suppliers in order to guarantee a supply chain that can deliver millions of masks on a timely schedule, our initial press release could give the reader the impression that we had millions of masks on hand. This is not the case. Rather we had been offered millions of masks and were attempting to vet that supply for quality and consistency while simultaneously vetting corresponding orders.
It was never our intention to leave any reader with the impression that we had masks on hand, but rather we were ready to take orders and stand as an intermediary in closing sales to provide masks for sale abroad. Regrettably, our third-party inspectors in Mexico inspected masks that were available for purchase but were determined to be substandard. We have been unsuccessful in obtaining any safe and functional substitute masks.
We therefore retract our prior press releases in their entirety and will henceforth cease any and all attempts to source or sell any masks.
About Praxsyn Corporation
Headquartered in West Palm Beach, Florida, Praxsyn Corporation works to realize the vision of medical professionals to improve the lives of their patients. Additional company information can be found at www.praxsyncorp.com.
Forward-Looking Statements
This press release contains forward-looking statements that are subject to many risks and uncertainties. Forward-looking statements include, among other things, statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations. Such risks and uncertainties include, among others, the inherent uncertainties associated with developing new products or technologies, regulatory approvals, unexpected expenditures, the ability to raise the additional funding needed to continue to pursue Praxsyn's business and product development plans and overall market conditions. These forward-looking statements are made as of the date of this press release, and Praxsyn assumes no obligation to update the forward-looking statements.We may use terms such as “projects,” “believes,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” “approximately,” or other words that convey the uncertainty of future events or outcomes to identify these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained herein, we caution you that forward-looking statements are not guarantees of future performance and that our actual results may differ materially from the forward-looking statements contained in this press release. As a result of these factors, we cannot assure you that the forward-looking statements in this press release will prove to be accurate.
Investor Contact:
TEN Associates LLC
Tom Nelson
480.326.8577